Godavari Drugs Times and Sales

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen
			Ausblick

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

Ausblick

Godavari Drugs Times and Sales (BOM)

Zeit	Kurs	Umsatz grafisch
Times and Sales Zur Zeit stehen keine Daten zur Verfügung
Kursrückgang	Kursanstieg	keine Kursänderung
(Balkenlänge beschreibt das Umsatzvolumen)

15:40		3 No-Brainer Stocks to Buy Right Now for Less Than $25
15:37		3 Reasons I'm Bullish on Royal Caribbean Stock
15:31		Visa and Mastercard Show Once Again Why Hyperinflation Fears Are Overblown
15:26		Will These 3 Potential Blockbuster Drugs Lift Bristol Myers Squibb?
15:25		Bitcoin clings to $23.5K as trader says BTC 'identical' to 2020 breakout
15:10		Why Buying Palo Alto Networks Now Is a Genius Move
15:10		1 Metric from Meta Platforms and Snap That Forebodes Trouble for Pinterest
15:05		These 3 Beaten-Down Stocks Just Keep Raising Their Dividends. Time to Buy?
15:00		Corporate America is divided on odds of US recession
15:00		Corporate America is divided on odds of US recession
15:00		Top 10 most famous computer programmers of all time
14:50		Medical Properties Trust Stock: Bear vs. Bull
14:47		Cocaine capital: Antwerp fears drug-related attacks may rise
14:40		Your Roth Is Your REIT's Best Friend. Here's Why.
14:34		Fear a Recession in 2023? Here Are 3 Stocks to Safeguard Your Portfolio
14:30		2 Stocks Down More Than 6% to Buy Right Now
14:30		Meta Platforms Stock Jumped by Over 20% Following Q4 Earnings. Was the Move Justified?
14:18		Mutual Funds Weekly: These money and investing tips can steer your portfolio around the market’s many obstacles
14:05		Manchester United vs. Crystal Palace Livestream: How to Watch Premier League Soccer From Anywhere - CNET
14:05		Ethereum's 2023 Bull Run: Why the Best Is Yet to Come
14:00		Barclays chief: the life lessons I have discovered during cancer treatment
14:00		Samsung's Galaxy S23 Faces Its Biggest Challenge, and It Isn't Apple - CNET
14:00		The Butterfly Effect: How Chaos Theory Muddles the Line Between Math and Art - CNET
14:00		Best Stock to Buy: Ford Stock vs. Plug Power Stock
14:00		Popular AI Like ChatGPT Could Be Just the Beginning for Data Center Stocks Like Nvidia
14:00		Better Buy: Novavax or BioNTech Stock?
13:59		Commerzbank kehrt in den Dax zurück
13:47		Ukraine updates: US sends Russian oligarch's money to Ukraine
13:47		TikTok: Why regulators are zeroing in on the popular app
13:47		Brazil sinks warship in Atlantic amid environmental concerns
13:47		Elon Musk found not liable in trial over 2018 Tesla tweets
13:47		International poll shows one in three would emigrate
13:43		Saudi Arabia: Executions thwart trust in reforms
13:43		Paco Rabanne, iconic fashion designer, dies at 88
13:43		World War II era bomb shuts rail lines in southern Germany
13:43		Is EU ready for life without Russian diesel?
13:43		Don't miss this once-in-a-lifetime green comet
13:43		Hindenburg: The short-seller taking on India's Gautam Adani
13:43		Kanjuruhan Tragedy: Indonesian football 4 months on
13:43		'Hitler Youth Salomon' Holocaust survivor Sally Perel dies at 97
13:43		Diagnosed with cancer? Psycho-oncology can help
13:43		Pressure on London to restitute artworks grows
13:43		Alice Cooper at 75: Shock rocker lives on
13:43		ECB hikes interest rates again in anti-inflation bid
13:39		Stone Age rock paintings discovered in France
13:39		Ewa Pajor's dedication sums up Wolfsburg's recipe for success
13:39		'20 Days in Mariupol' wins Sundance audience award
13:39		RECOMMENDED — 80 years ago, Nazi Germany surrendered in Stalingrad. Russia uses the commemoration for its campaign against Ukraine
13:39		Deutsche Bank announces highest profits in 15 years
13:39		Cult East German novelist now published in English

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Godavari Drugs Aktie VALOR 1177148 / ISIN INE362C01012

Godavari Drugs Times and Sales (BOM)

Times and Sales

Eintrag hinzufügen Eintrag bearbeiten

Analysen zu Godavari Drugs Ltd Dematerialised

Weitere Meldungen